PRA Group Reports First Quarter 2017 Results
May 09, 2017 20:14 pm UTC| Business
NORFOLK, Va., May 09, 2017 -- PRA Group (Nasdaq:PRAA), a global leader in acquiring and collecting nonperforming loans, today reported its financial results for the first quarter of 2017. The company reported diluted...
Chembio Diagnostics Reports First Quarter 2017 Financial Results
May 09, 2017 20:14 pm UTC| Business
MEDFORD, N.Y., May 09, 2017 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the quarter ended March 31, 2017. ...
Chembio Diagnostics Reports First Quarter 2017 Financial Results
May 09, 2017 20:14 pm UTC| Business
MEDFORD, N.Y., May 09, 2017 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the quarter ended March 31, 2017. ...
Chembio Diagnostics Reports First Quarter 2017 Financial Results
May 09, 2017 20:14 pm UTC| Business
MEDFORD, N.Y., May 09, 2017 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the quarter ended March 31, 2017. ...
Chembio Diagnostics Reports First Quarter 2017 Financial Results
May 09, 2017 20:14 pm UTC| Business
MEDFORD, N.Y., May 09, 2017 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the quarter ended March 31, 2017. ...
Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights
May 09, 2017 20:14 pm UTC| Business
VY-AADC01 interim Phase 1b data recently presented at American Academy of Neurology and American Association of Neurological Surgeons meetings; program on track to report 6-month data from Cohort 3 and longer-term data...
Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights
May 09, 2017 20:14 pm UTC| Business
VY-AADC01 interim Phase 1b data recently presented at American Academy of Neurology and American Association of Neurological Surgeons meetings; program on track to report 6-month data from Cohort 3 and longer-term data...